Report cover image

Clinical Trial Support Services Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385699

Description

Clinical Trial Support Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial support services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for clinical trial support services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical trial support services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Service: Clinical Trial Site Management; Data Management; Patient Recruitment Management; Administrative Staff; Institutional Review Board (IRB); Other Services

2) By Phases: Preclinical Studies; Phase I; Phase II; Phase III; Phase IV

3) By Application: Oncology; Central Nervous System (CNS) And Mental Disorders; Cardiovascular Diseases; Infectious Diseases; Bood Disorders; Other Applications

Subsegments:

1) By Clinical Trial Site Management: Site Selection; Site Initiation; Site Monitoring; Site Close-out

2) By Data Management: Data Collection; Data Validation; Electronic Data Capture (EDC); Statistical Analysis

3) By Patient Recruitment Management: Patient Screening; Enrollment Strategy; Retention Services

4) By Administrative Staff: Clinical Research Coordinators; Project Managers; Regulatory Affairs Specialists

5) By Institutional Review Board (IRB): Ethical Review; Protocol Review; Compliance Monitoring

6) By Other Services: Regulatory Consulting; Quality Assurance; Medical Writing; Investigator Training

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Eli Lilly and Company; Novo Nordisk A/S; Iqvia Inc.; Laboratory Corporation of America Holdings (Labcorp); ICON plc; SGS S.A.; Eurofins Scientific SE; WuXi AppTec; Syneos Health; Catalent Inc.; Charles River Laboratories International Inc.; Medpace Holdings Inc.; Pharmaron; MARKEN Ltd.; Novotech; ClinChoice Private Limited; Medidata Solutions Inc.; Premier Research; Quotient Sciences Ltd.; Caidya; MMS Holdings Inc.; Celerion Inc.; Parexel International (MA) Corporation; Alcura Health; Almac Group; Brighter Health Network LLC

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Chlamydia Market Characteristics
3. Chlamydia Market Trends And Strategies
4. Chlamydia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Chlamydia Growth Analysis And Strategic Analysis Framework
5.1. Global Chlamydia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chlamydia Market Growth Rate Analysis
5.4. Global Chlamydia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chlamydia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chlamydia Total Addressable Market (TAM)
6. Chlamydia Market Segmentation
6.1. Global Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture Tests
Nucleic Acid Amplification Test (NAAT)
Direct Fluorescent Antibody Test
Serology Tests
Other Test Types
6.2. Global Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Other Routes Of Administration
6.3. Global Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Other End Users
6.4. Global Chlamydia Market, Sub-Segmentation Of Culture Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urethral Swab Culture
Endocervical Swab Culture
Urine Culture Test
Conjunctival Swab Culture
6.5. Global Chlamydia Market, Sub-Segmentation Of Nucleic Acid Amplification Test (NAAT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR (Polymerase Chain Reaction)
Transcription-Mediated Amplification (TMA)
Strand Displacement Amplification (SDA)
Loop-Mediated Isothermal Amplification (LAMP)
6.6. Global Chlamydia Market, Sub-Segmentation Of Direct Fluorescent Antibody Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DFA Test For Urogenital Chlamydia
DFA Test For Ocular Chlamydia
DFA For Respiratory Chlamydia Detection
6.7. Global Chlamydia Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunofluorescence Assay (IFA)
Western Blot
6.8. Global Chlamydia Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunochromatographic Rapid Test
Lateral Flow Immunoassay
Hybrid Capture Test (HCT)
7. Chlamydia Market Regional And Country Analysis
7.1. Global Chlamydia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chlamydia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chlamydia Market
8.1. Asia-Pacific Chlamydia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chlamydia Market
9.1. China Chlamydia Market Overview
9.2. China Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chlamydia Market
10.1. India Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chlamydia Market
11.1. Japan Chlamydia Market Overview
11.2. Japan Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chlamydia Market
12.1. Australia Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chlamydia Market
13.1. Indonesia Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chlamydia Market
14.1. South Korea Chlamydia Market Overview
14.2. South Korea Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chlamydia Market
15.1. Western Europe Chlamydia Market Overview
15.2. Western Europe Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chlamydia Market
16.1. UK Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chlamydia Market
17.1. Germany Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chlamydia Market
18.1. France Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chlamydia Market
19.1. Italy Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chlamydia Market
20.1. Spain Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chlamydia Market
21.1. Eastern Europe Chlamydia Market Overview
21.2. Eastern Europe Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chlamydia Market
22.1. Russia Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chlamydia Market
23.1. North America Chlamydia Market Overview
23.2. North America Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chlamydia Market
24.1. USA Chlamydia Market Overview
24.2. USA Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chlamydia Market
25.1. Canada Chlamydia Market Overview
25.2. Canada Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chlamydia Market
26.1. South America Chlamydia Market Overview
26.2. South America Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chlamydia Market
27.1. Brazil Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chlamydia Market
28.1. Middle East Chlamydia Market Overview
28.2. Middle East Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chlamydia Market
29.1. Africa Chlamydia Market Overview
29.2. Africa Chlamydia Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chlamydia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chlamydia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chlamydia Market Competitive Landscape And Company Profiles
30.1. Chlamydia Market Competitive Landscape
30.2. Chlamydia Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Chlamydia Market Other Major And Innovative Companies
31.1. AstraZeneca
31.2. Abbott Laboratories
31.3. GlaxoSmithKline Plc
31.4. Gilead Sciences Inc.
31.5. Danaher Corporation
31.6. Becton, Dickinson and Company
31.7. Hologic Inc.
31.8. Quidel Corporation
31.9. Bio-Rad Laboratories Inc.
31.10. Ortho Clinical Diagnostics
31.11. DiaSorin SpA
31.12. Eiken Chemical Co. Ltd.
31.13. MedMira Inc.
31.14. GenMark Diagnostics Inc.
31.15. Aytu BioScience Inc.
32. Global Chlamydia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chlamydia Market
34. Recent Developments In The Chlamydia Market
35. Chlamydia Market High Potential Countries, Segments and Strategies
35.1 Chlamydia Market In 2029 - Countries Offering Most New Opportunities
35.2 Chlamydia Market In 2029 - Segments Offering Most New Opportunities
35.3 Chlamydia Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.